Par Pharmaceutical

From Wikipedia, the free encyclopedia

Par Pharmaceutical Companies, Inc.
Type of Company	Public NYSE: PRX
Founded	(1978)
Headquarters	Woodcliff Lake, New Jersey, United States
Industry	Pharmaceuticals
Products	>110 Generic and branded specialty pharmaceuticals
Revenue	$433,200,000 USD (2005)
Net income	$12,600,000 USD (2005)
Employees	775 (2005)
Website	http://www.parpharm.com

Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceuticals. Par was founded in 1978 and initially traded on the New York Stock Exchange in 1987. Par is currently the fifth largest generic pharmaceutical company in the United States.^[1]

Contents 1 Facilities 2 Products[2] 3 References 3.1 Notes

[edit] Facilities

The company is based in the United States, with corporate headquarters in Woodcliff Lake, New Jersey and additional facilities for research, manufacturing and distribution in Suffern, New York, Spring Valley, New York and Somerset, New Jersey.

[edit] Products^[2]

as of Nov 2006

Acebutolol Aciclovir Allopurinol Amiloride Amiodarone Amoxicillin (alone and in combination with Potassium clavulanate) Aspirin (alone (branded as 'ZORprin')) and in combination with carisoprodol) Atenolol Benztropine Biperiden (branded as 'Akineton') Buspirone Cabergoline Captopril (branded as 'Capoten') (alone and in combination with Hydrochlorothiazide (combination branded as 'Capozide')) Carisoprodol (in combination with aspirin) Cefaclor Cefprozil Cefalexin Chlordiazepoxide (alone and in combination with amitriptyline) Cholestyramine (generically and branded as 'Questran') Ciprofloxacin Clomifene Clonazepam Clozapine Cyproheptadine Diphenoxylate (in combination with Atropine) Doxycycline Doxazosin Doxepin Enalapril Estazolam Etodolac Famotidine Flecainide Fluconazole Flutamide Fluticasone Fluoxetine Fluphenazine Glibenclamide (in combination with Metformin) Hydralazine (alone and in combination with Hydrochlorothiazide (combination branded as 'Hydra-Zide')) Hydroquinone Hydroxyurea

Ibuprofen (branded as 'IBU') Imipramine Indapamide Isosorbide Leflunomide Leuprolide Lisinopril Lovastatin Meclizine Megestrol (sold generically and branded as 'Megace') Meloxicam Mercaptopurine Metaproterenol Metformin (alone and in combination with Glibenclamide) Methimazole Methylprednisolone Minocycline Minoxidil Mirtazapine Nabumetone Nicardipine Nizatidine Nystatin Oxaprozin Paroxetine Pergolide Polyethylene glycol Potassium chloride Prochlorperazine Propoxyphene Quinapril Ranitidine Ribavirin (generically and branded as 'RibaPak' and 'Ribasphere') Selegiline Sotalol Silver sulfadiazine (branded as 'SSD' and 'SSD AF') Tetracycline (branded as 'Sumycin') Ticlopidine Tizanidine Torasemide Tramadol Triazolam Verapamil

[edit] References

• ParFacts. Par Pharmaceutical Companies, Inc. Retrieved on 2006-11-23.
• Company Milestones. Par Pharmaceutical Companies, Inc. Retrieved on 2006-11-23.

[edit] Notes

1. ^ Introduction for Investors. Par Pharmaceutical Companies, Inc. Retrieved on 2006-11-23.
2. ^ Products. Par Pharmaceutical Companies, Inc. Retrieved on 2006-11-24.